Stacey Bilinski

Stacey has served as the VP, Clinical Operations since March 2022. She brings more than 30 years of diverse clinical and operations experience to IN8bio, ranging from CROs and small/medium pharma to start-up companies. Prior to joining In8Bio, Ms. Bilinski was the global senior director of clinical operations at Taiho Oncology Inc, where she ran the life cycle management or the Lonsurf program as well as numerous first in-human and early phase studies. Previously, she was Executive Director of clinical operations at Onconova, where she directed clinical operations for programs in MDS, pancreatic, and head and neck cancer. Earlier, Ms. Bilinski spent 16 years working at CROs in clinical operations. In these roles, she managed clinical development programs for rare diseases as well as cardiovascular compounds in both early and late-stage development. Ms. Bilinski has a bachelor’s degree from Rutgers University.